Istvan Petak introduced Nabil Hafez as the new CEO of Genomate Health
Istvan Petak, Founder and Chief Scientific Officer at Genomate Health, shared on LinkedIn:
“It is my great pleasure to introduce Nabil Hafez, to my friends and the world as the CEO of Genomate Health.
I am thankful to Nabil for joining us and advancing Genomate to its next growth phase.
Nabil has a biology, bioinformatics, computer science, and business administration background. Nabil was part of the team that completed the Human Genome Project in 2003 at the Broad Institute in Boston. Over the past twenty years, he has gained tremendous experience in diagnostic and software development and commercialization in the genomic space.
As a physician-scientist founder, it has always been my dream to find someone with this fantastic experience to help us carry out the mission of Genomate and deliver a new class of medical tools for precision oncology.
Now I can focus on my scientific journey, serve Genomate Health as Chief Scientific Officer, and continue advocating for precision oncology worldwide.
Welcome to the team, Nabil! I am excited to work with you and create fantastic solutions for cancer patients and their medical teams.”
More posts featuring Istvan Petak.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023